Retraction Note: MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex
1 Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
2 Division of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy.
3 Hematology, Department of Biotecnologie Cellulari ed Ematologia, Sapienza, University of Rome, Rome, Italy.
4 Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
5 Department of Microbiology & Immunology, Brody School of Medicine at East Carolina University, Greenville, NC, USA.
6 Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. mandreef@mdanderson.org.